Paris - Delayed Quote EUR

ATON (ALTAO.PA)

0.0088
+0.0003
+(3.53%)
As of 1:50:29 PM GMT+2. Market Open.
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
614
614
612
1.5650
147.1310
Cost of Revenue
123
123
164
212.2130
256.5140
Gross Profit
491
491
448
-210.6480
-109.3830
Operating Expense
660
660
2,536
591.7080
270.4250
Operating Income
-169
-169
-2,088
-590.1430
-123.2940
Net Non Operating Interest Income Expense
-267
-267
-172
20.5890
31.0690
Pretax Income
-1,072
-1,072
-7,096
-572.4360
296.6540
Tax Provision
0
0
-26
--
--
Net Income Common Stockholders
-1,101
-1,101
-7,869
-563.5700
-69.1590
Diluted NI Available to Com Stockholders
-1,101
-1,101
-7,869
-563.5700
-69.1590
Basic EPS
-0.04
-0.00
-0.03
-0.00
-0.00
Diluted EPS
-0.04
-0.00
-0.03
-0.00
-0.00
Basic Average Shares
416,958.7260
584,515.2950
302,653.8460
273,743.5040
261,249.2460
Diluted Average Shares
416,958.7260
584,515.2950
302,653.8460
273,743.5040
261,249.2460
Total Operating Income as Reported
-1,378
-1,378
-2,108
-590.1440
-123.2940
Rent Expense Supplemental
60
60
45
--
--
Total Expenses
783
783
2,700
591.7080
270.4250
Net Income from Continuing & Discontinued Operation
-1,071
-1,071
-7,070
-572.4370
296.6540
Normalized Income
-437
-437
-1,923.7266
-572.4370
11.7695
Interest Income
0
0
2
77.1590
52.7480
Interest Expense
256
256
32
56.5700
21.6790
Net Interest Income
-267
-267
-172
20.5890
31.0690
EBIT
-816
-816
-7,064
-515.8660
318.3330
EBITDA
-22
-22
-714
-507.7480
325.4680
Reconciled Cost of Revenue
123
123
164
212.2130
256.5140
Reconciled Depreciation
177
177
6,350
8.1180
7.1350
Net Income from Continuing Operation Net Minority Interest
-1,071
-1,071
-7,070
-572.4370
296.6540
Total Unusual Items Excluding Goodwill
-634
-634
-4,838
0
387.5980
Total Unusual Items
-634
-634
-4,512
0
387.5980
Normalized EBITDA
612
612
3,798
-507.7480
-62.1300
Tax Rate for Calcs
0
0
0
0
0.0003
Tax Effect of Unusual Items
0
0
-17.7266
0
102.7135
12/31/2021 - 12/21/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ALTHX.PA Theranexus Société Anonyme
1.5100
-1.95%
 
ALBPS.PA Biophytis S.A.
0.1596
+2.31%
 
GNFT.PA Genfit S.A.
3.6480
-3.54%
 
VLA.PA Valneva SE
2.8240
-2.28%
 
DBV.PA DBV Technologies S.A.
1.9960
-12.08%
 
LPTX Leap Therapeutics, Inc.
0.3921
-4.13%
 
CERO CERo Therapeutics Holdings, Inc.
0.5696
-0.92%
 
CABA Cabaletta Bio, Inc.
1.5400
+18.46%
 
APLT Applied Therapeutics, Inc.
0.4611
-4.94%
 
JAGX Jaguar Health, Inc.
6.00
-2.84%